JAXIPREM Trademark

Trademark Overview


On Wednesday, January 6, 2010, a trademark application was filed for JAXIPREM with the United States Patent and Trademark Office. The USPTO has given the JAXIPREM trademark a serial number of 77906061. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2011. This trademark is owned by Pfizer Inc.. The JAXIPREM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
jaxiprem

General Information


Serial Number77906061
Word MarkJAXIPREM
Filing DateWednesday, January 6, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2010

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, February 14, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 14, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 13, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 2010PUBLISHED FOR OPPOSITION
Wednesday, April 28, 2010NOTICE OF PUBLICATION
Wednesday, April 14, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 14, 2010ASSIGNED TO LIE
Friday, March 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 25, 2010ASSIGNED TO EXAMINER
Wednesday, January 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 9, 2010NEW APPLICATION ENTERED IN TRAM